A detailed consideration of the radiation dosimetry required in radiobiology is given in Sections 3, 4 and 5. A brief introduction of the more important concepts is given here to facilitate the discussion of relationships between dosimetric quantities and those describing the degree of biological effect.
Soon after their discovery ionizing radiations were used for clinical treatment and biological experiments. In order to quantify the amount of exposure, and to intercompare irradiation methods and results, a unit for the measurement of radiation dose was needed. Such a unit, the roentgen (r), was introduced in 1928 (Taylor, 1958) by the International Commission of Radiological Units (ICRU). Most of the radiological work during the decades from 1930 to 1960 was based on this unit, which, however, was a unit of exposure and not of absorbed dose. Nevertheless, the unit worked in practice since reproducible application of x rays and gamma rays in the field of radiation therapy needed only an arbitrary but welldefined unit. Intercomparisons of exposure measurement among different nations have yielded values that differ by no more than approximately one percent.
Some limitations in the use of the roentgen and of the corresponding quantity, exposure, arose with the introduction of charged particles and high-energy photon radiation into radiation therapy, since the exposure was defined only for x rays and gamma rays and was useful only for photon energies up to a few MeV.
In 1962 the ICRU proposed a more complete set of physical quantities needed to describe the interaction of a radiation field with matter, including the fluence for characterizing a radiation field, and redefined the absorbed dose for characterizing the energy imparted to irradiated matter (ICRU, 1964 (ICRU, , 1971 . These welldefined physical quantities are useful in a number of circumstances, but some are of limited applicability for dosimetry in radiobiology. For example, the number of photons impinging per unit area on the irradiated sample (fluence) is rarely useful since many of the photons pass through the sample without interaction, i.e., the fluence alone does not provide the necessary information on those interactions that actually cause the radiation effect. The most appropriate quantity for characterizing the amount of radia-3 tion to which the sample has been exposed is the absorbed dose, the detailed definition of which is given in ICRU Report 19 (ICRU, 1971 ) and discussed in Section 4 of the present report. Absorbed dose is expressed in terms of energy imparted per unit mass of the irradiated material. The SI unit of absorbed dose, J kg-1 , has been given the special name of gray (Gy), related to the older unit rad (100 erg g-1 ) by the relationship 1 Gy = 1 J kg-1 = 100 rad.
The concept of radiation quality as applied to radiobiology has been described in ICRU Report 16, page 1 (ICRU, 1970a) .
Specification of radiation quality in radiobiology involves a description of the microscopic distribution of energy deposition (see Section 3.1). The form of the specification required will depend upon the use to be made of the information. If all that is required is an assurance that radiations used by a number of different investigators would not generally be considered to differ appreciably in radiation quality, a simple specification (such as tube voltage and filtration of x rays, the relevant radionuclide for gamma rays, or the beam energy for electrons and heavy particles) should be sufficient, especially for high energy x rays, gamma rays, and electrons. On the other hand, for the interpretation of data relating to the relative biological effectiveness (RBE) of radiations, a description of the microscopic distribution will generally be advisable, which may take into account the radiobiological hypothesis to be tested.
Quantitative Relationships in·Radiobiology
Quantitative relationships are developed in this section to present an adequate background for the development of concepts and definitions, and to provide a more complete understanding of radiobiologi-. cal effects and of the importance of dosimetry.
Among the various quantitative relationships of interest in radiobiology, the dose response curve is the most prominent and it will, therefore, be discussed in detail. It should be noted, however, that there are other relationships that are of significance. Examples are: the dependence of effect on absorbed dose rate, the dependence of RBE on absorbed dose, and the dependence of the cellular inactivation cross-section on linear energy transfer, LET (see Section 3.1). A given dose-effect relationship may change with a physiological variable, such as the oxygen tension in the specimen. The study of such relationships can yield important perspectives on basic biophysical processes that are different from those afforded by dose-response curves.
Functional relationships between biophysical variables can be shown on graphs using either linear or non-linear scales. It is frequently possible to approximate these relations by comparatively simple analytical expressions which, in turn, depend on one or more parameters. Because of the limited accuracy of many radiobiological determinations, it is often possible to fit the data points to more than one function within limits that are statistically acceptable. It is then desirable to derive confidence regions of the parameters of these functions (Kellerer and Brenot, 1973) to evaluate the relative goodness of such fits.
The functions chosen for the fitting process are often selected on the basis of postulated mechanisms (models). It must be stressed, however, that agreement showing the data to be not inconsistent with the model, while a necessary condition for proof, does not in itself constitute proof of the correctness of the model. However, whether the model is correct or not, the analytical expressions and their parameters can be convenient means of characterizing the relationships, and it is to this end that various expressions and parameters are considered in Section 2.2.1.
Dose-Effect Relationships
Radiation in sufficient amount can cause the death of cells, tissues, or whole animals. It can also cause many kinds of functional or phenotypic changes in these specimens. These include, for example, mutagenic, oncogenic or teratogenic changes, as well as cytological changes such as nonlethal chromosome aberrations, small colony formation and other forms of heritable damage.
In general, these changes, including lethality in cell or animal populations, show a greater frequency as the dose increases but the form of the dose-effect relationship may be simple or complex. Also it may change, over a broad dose range, from one simple functional relation to another.
Representative forms of dose effect curves are shown in Figure 2 .1, and are discussed later in Section 2.2.4. The effect may start out as a function of dose in linear form (curve B), with negative curvature (curve A), or with positive curvature (curve C). Also the curve may not separate from the abscissa until some finite value ofD is reached (curve D). At high doses the effect may continue to increase
Any one of the curves to the left of the break can, in principle, assume, at higher dose, the shape of any one of the curves to the right of the break.
(curve E), saturate (curve F, perhaps dictated by a limit on the amount of effect possible), or decline (curve G, perhaps as a result of competing processes).
Cell killing and morbidity and/or mortality of tissues, organs and animals are effects of radiation that have been rather thoroughly studied and the form of the dose-effect relationship takes on certain characteristics for given types of cells or tissues and conditions.
To examine these relationships further, it is frequently more convenient to express the response in terms of the "unaffected" members of the population, i.e., the survivors. Furthermore, in practice it is often the fraction of surviving members of the population that is measured, rather than the fraction killed.
In the following discussion a distinction will be made between cell survival curves (the response of a population of single cells, as a function of dose) and tissue and organ survival (the response of populations or subpopulations of cells, organized into tissue, as a function of dose).
Cell Survival Curves
As noted in Section 2.2 above, curves are often fitted to data for convenience, and such fitted curves are not necessarily intended to imply a judgment as to the mechanism of radiobiological action or the validity of a given model. The survival curve of a homogeneous population of single cells (or microorganisms) is generally found to have one of three shapes (Figure 2 .2). The simplest of these is the single exponential, curve A, fitted by the equation:
where S (D) is the surviving fraction after a single absorbed dose D, and k is the slope of the curve on a semilogarithmic plot. The reciprocal of k, D 0 , (the mean inactivation dose), is the dose D required to reduce S (D) by a factor of e. The dose to reduce survival to 37 percent [i.e., -100 (1/e) percent] is designatedD 37 and for exponential survival, curve A, D 37 = D 0 • As a model of inactivation, in Equation (2.1) the inactivation constant k represents the net sensitivity of each cell and may be associated with a net target volume (Lea, 1946; Hall, 1953) . It may also represent the sum of sensitivities contributed by a number of subtargets, each cell having the same number and type. The modification or inactivation of a single subtarget results in the inactivation of the cell. In such an instance, D 0 is less than the mean inactivation dose of any one subtarget, Do,i> being given by:
where Do,; is the mean inactivation dose for subtargets of type i.
A population of cells may contain a mixture of two (or more) subpopulations which separately would follow an exponential dose-effect curve. In the simplest case of a mixture consisting of population fractions a and b, (a + b = 1), the survival curve would be: In the instance where more than two exponentially surviving subpopulations are involved, the initial slope will tend to reflect the most sensitive and the final slope the most resistant moiety.
A second survival curve frequently observed is B in Figure 2 .2. Such a curve may be described by the "mul"itarget, single-hit" survival expression:
(2.4) where the inactivation constant kn is the sensitivity of each of n targets, each of which must be hit to kill a cell. Shoulder-type survival curves that appear to have a negative initial slope and that become exponential at survivals below about 10 percent may be more closely fitted by a "modified multitarget, singlehit" curve:
Here, cells in a homogeneous population are inactivated by the radiation according to two different modes; these may reflect characteristics of the cells, the radiation, or both. In the first mode, the survival of cells is reduced exponentially within an effective inactivation constantk 1 • In the second mode, survival is reduced according to Equation (2.4) with kn representing the effective inactivation constant of each of n targets, each of which must be inactivated for a cell to be killed by this mode. Clearly, if kn approaches zero or if n approaches infinity or unity, simple exponential survival results, Equation (2.1). Similarly, if k 1 approaches zero, the initial slope of the survival curve will approach, dS{D) {2.6) and this expression is zero at D = 0.
This relationship between the survival parameters in Equation (2.5) and the quantities identifiable on a survival curve is shown in Figure 2 .4. The initial slope of the curve gives 1 D 0 since 1 D 0 = 1Jk 1 • If the effective mean inactivation dose for each of the n targets is nDo = llk,,, then with l/D 0 being the slope at largeD, (2.7)
For n > 1 one has;
(2.8)
The shoulder width (sometimes termed quasithreshold dose) of the curve, D q, is equal to the dose at which a back extrapolation of the exponential part of the curve crosses the level at which the surviving fraction is equal to 1. 0; the back extrapolation intersects the ordinate at the extrapolation number, n . The parameters n, Dq, andD 0 are related,
where ln n is the normalized shoulder, width i.e., the shoulder width, normalized by D 0 •
In the instance of a heterogeneous population in which each fraction survives according to Equation related to the reciprocals of the initial slopes of each curve by, (2.10) where u; is the fraction of cells of initial slope l/ 1 D 0 ,;, (Iu; = 1). The extrapolation number observed will not reflect the distribution of n values in the population iftheD 0 values differ. In that case, the observed value for n will be approximated by, (2, 11) where Ur is the fraction of the population having the largest D 0 • On the other hand, if all moieties of the population have the same D 0 , n will be an average value, i.e., n = ~u;n; i (2,12)
In addition to the foregoing effects on the extrapolation number that are observed with a mixed population, when the population mixture also involves D 0 differences, the survival curve will frequently contain inflexions (e.g., see Elkind and Sinclair, 1965; Elkind and Whitmore, 1967; Sinclair, 1966 Sinclair, , 1969 . Further, in addition to controlling the magnitude of the extrapolation number observed, Equation (2.11), the cells having the largest D 0 will constitute the principal survivors after large doses as sketched for exponential survival in Figure 2 ,3,
The third shape of survival curve observed with cells is C in Figure 2 .2. In contrast to A and B ~ where the relative effect per unit dose is constant (A) or approaches a constant value (B )-in this case the relative effect per unit dose increases throughout the range of observation (Sinclair, 1966) . In general, the rate of increase may be such that a polynomial in the dose is required to describe the data adequately; i.e.,
where a, {3, y, ···are constants,
In practice, however, a constant rate of increase of the slope of the curve on a semilogarithmic plot, is often found to be adequate, i.e., i.e., the first derivative of the curve is a straight line, as has been pointed out using practical examples (Sinclair, 1966):
( 2.15) where a has the same relationship to curve C in Figure 2 .2 that ki. i.e., (l/ 1 D 0 ) has in Figure 2 .4. In a mixed population one deals with a superposition of functions of the form of Equation (2.15) with different parameters a and /3, which may result in an overall survival curve resembling that obtained with Equation (2.5). The initial slope of the resulting curve is given by,
(2.16) but in general the moiety with the smallest f3 will largely control the observed survival at high doses.
The expression containing a linear plus a quadratic term seems to fit many experimental circumstances and has been the basis of several recent theoretical approaches.
A method of describing a survival curve independent of particular models is also useful (Kellerer and Hug, 1972) , which will now be summarized: A survival probability S (D) represents an integral probability distribution. As such, its negative derivative, s (D ), is a differential probability distribution, Figure  2 .5. A survival curve may be characterized in part by its moments and its average dose l5;
i.e., the first moment of the differential distribution; or equivalently D=f-s(D)dD (2.17a)
the area under a linear plot of the survival curve.
The second moment of the distribution is,
and from the first and second moments the variance may be determined,
Of particular interest is the "relative steepness" of the curve, l];, (2.20) where u is the standard deviation of D about D. For an exponential survival curve, S (DJ = e-kn, the mean dose is Ii = l/k, and u = D and i_fJ = 1. For curves having shapes B and C in Figure 2 .2, i_fJ > 1; in general, the smaller the initial slope, and the broader the shoulder width D" relative to the mean dose, the smaller u will be and the larger l];. This is illustrated in Figure 2 steepness of the three curves is:
the subscripts referring to the curves in Figure 2 .5.
The parameters l5, u, and i _/J reflect the shape of the survival curve mainly at low doses or in the first decade of survival. In a mixed population, u2 will be larger than the mean of the variances for the subpopulations. For this reason, the steepness of a mixed population generally will always be less than the average steepness of the subpopulations. Although increasing steepness qualitatively reflects increasing shoulder width, i _/J and D do not uniquely specify a survival curve even in the high survival region.
Organ and Animal Survival
An organ can be regarded simplistically as a population of mostly functional cells, the size of which is maintained within rather narrow limits. The cell population may respond to radiation exposure as described above, i.e., the surviving fraction or the fraction of functionally-intact cells will decrease with increasing dose. The functional capacity and even viability of the organ will be jeopardized when the surviving fraction, or surviving functional fraction, has fallen below some critical level, which will differ among organs and from animal to animal. Organ failure may in tum lead to illness or death of the individual, in hours to days or weeks following exposure. Further, the numbers of animals committed to a given experiment is frequently limited to fewer than 100 for practical reasons. Such animal survival data are frequently plotted on linear coordinates (Figure 2 .6).
Tumor sterilization concerns the integrity of one or more populations of cells considered as a whole, in the same way that lethality in an animal may depend on the integrity of individual organs. The number of tumors ordinarily available for test is also limited by practical constraints; as a consequence, a linear plot is most frequently encountered in this case as well (Figure 2 .6).
In Figure 2 .6, curve A could correspond to the fraction of animals surviving, for a given length of time, t, as a function of dose; the lethal dose for 50 percent survival scored at a specified time, t, after irradiation is designated the LD 5 o1t· In connection with tumor irradiation, frequently the proportion that does not regrow in a given length of time is plotted as curve B, for example. The 50 percent dose in this case is designated tumor control dose, TCDso 1 t.
where t is the period of observation after exposure. In the instance where tumor sterilization is plotted, the 50 percent effective dose would be designated TCDso·
The slopes (D) of the survival curve represents the rate of inactivation at that particular dose level and usually maximizes at 50 percent survival. In many practical situations, the variation of the slope about this maximum approximates closely to a normal survival, and the standard deviation of the dose may be read from the probit plot as the dose increment between survivals 16 percent and 50 percent or 50 percent and 84 percent. Or, more conveniently, the spread in response can be specified in terms of the doses corresponding to 90 percent and 10 percent survival read off from the straight line probit plot (extrapolated beyond the experimental data if necessary). An analogous situation exists for curve B in Figure 2 .7, for tumor cure.
In general, the more heterogeneous the population of cells may be in any one animal or tumor, the more uncertain will be the association of the doses at the 50 percent effect level, with the response of a given subpopulation. But, in addition, ifthere is variability from animal to animal, or tumor to tumor, this will lead to a shallower dose-effect curve; that is, a curve with larger u (Kellerer and Hug, 1972) . As a consequence, the steepness !/J, will be less.
Curves of Functional or Phenotypic Change
Among the cells, tissues, or animals that may survive radiation exposure, induced changes in cells may become manifest. These may take various forms and may give rise to, for example, mutagenic, oncogenic, or teratogenic alterations. Such changes are usually detected as low frequency events, their frequency initially increasing with dose, sometimes to a plateau before a possible decrease. When the popula-tion at risk is large enough, it may be useful to plot the induction frequency vs. dose on semilogarithmic coordinates as is done in the case of cell survival, or even on full logarithmic coordinates. When tissues or animals are exposed, the limited data that result from experiments of conventional size are more commonly plotted on linear coordinates.
In Figure 2 .1, the induction of phenotypic change E (D) is plotted on linear coordinates to show that for small doses, the curve may have one of several shapes, and for large doses it may assume a maximum or a plateau. Frequently, such data may be fitted by a polynomial:
where it is assumed that E (D) is the induced rate above the controls, although for a limited dose range, a linear, a quadratic, or a linear plus a quadratic dose dependence is usually sufficient. A full-logarithmic plot may be useful in making graphical estimates of the exponents since the slope of a straight line region gives the power of the dose that dominates in that region (e.g., Figure 2 .8). A plot of E(D)/D as a function of D is also in wide use, particularly since it yields a as the intersection of the curve on the ordinate, and f3 as the slope of the straight line obtained, provided that terms with an exponent of 3 or higher are non-contributory.
Phenotypic or functional changes require that the properties of at least one cell be altered. The susceptibility to alteration may depend on many factors and these may vary among cells. Consequently, the dose dependence of induced changes could reflect a mixed population response. In that event, a is given by Equation (2.16) but, in general, the moiety with the largest value of f3 will control the magnitude of E (D) at doses in the quadratic region of the induction curve.
Damage and Repair

Repair, Repopulation, and Recovery
When the degree of a radiation effect depends upon the overall dose delivery time-i.e., the dose rate, or the protraction of a fractionated dose sequence -this frequently reflects the biochemical and biophysical interplay of reparative processes. Even if the end point of interest reflects the response of a population of cells or an organism as a whole, reparative processes may start in the individual cells that comprise the target. Definition: Repair: The partial or complete restoration of functional integrity in cells following damage caused by radiation.
Operationally, repair means that after irradiation a cell responds as though it had received a smaller dose than under conditions in which damage is more fully expressed. The ability to observe repair implies, therefore, that a comparison is made with a treatment of reference. Full repair indicates that cells respond as though they had not been previously irradiated. (Repair embraces processes sometimes referred to as: bypassing of damage; shedding of damage; compensating for damage; elimination of damage; and/or the specific biochemical reversal of damage.) Definition: Repopulation: The replacement of functional cells (usually by proliferation) following or during an irradiation. Repopulation refers to those cells upon which the biological end point depends and usually reflects increases in the numbers of differentiated cells as well as their progenitors. Repopulation may result from cells that were unaltered by the radiation (e.g., due to migration into the irradiated field) but may also reflect a contribution from surviving cells. In a given case, repopulation could be influenced by systemic responses induced by the radiation (e.g., homeostatic responses).
Definition:
Recovery: (1) The change(s) in response in a cell, an organ, or an organism after irradiation that tend to restore functional integrity. This term includes not only repair of target cells, and/or repopulation in the irradiated field, but also abscopaF interactions that influence the magnitude of the effect observed.
Recovery processes need not always lead to a reduced biological effect. Under some circumstances, radiation delivered at a reduced dose rate, or with protracted exposures each delivered at a high dose rate, may result in an enhanced response. Such situations are exceptional. They usually result from changes that enhance the response of the system to an extent sufficient to mask or outweigh repair and/ or repopulation. For example, if during a treatment course, the resistance of the target cells decreases sufficiently-as might be the case in a tumor if hypoxic cells become oxygenated-the net effect could be an enhanced response even though repair and repopulation occur.
Cell-Age Dependence
Experimental evidence indicates that various metabolic and biological processes are correlated with the position of a cell in its division cycle. Metabolic pathways are turned on, off, or modulated as cells age in cycle from birth (meiosis or mitosis) to division, differentiation, and/or maturation. In cells undergoing repeated division cycles (e.g., stem cells, cell renewal systems, or cancer cells), some of the cyclic events related to the synthesis of deoxyribonucleic acid (DNA) have been established. Since the timing of these events is relatively easy to determine, and since DNA is a molecule of critical biological importance, the DNA synthesis cycle has been used as a "cell-age scale" in reference to which radiation responses of a cell in its cycle have been measured. 2 Definition: Cell-Age Response Pattern: The cyclic variation through the division cycle of the degree of effect produced by radiation. Figure 2 .9 shows an age-survival pattern of mammalian cells irradiated with a single dose of x or gamma rays delivered at high dose rates. Here response is cell killing-determined from survival measurements as measured by proliferative ability-but response can also be mutation, transformation, and so on. Although the DNA synthesis cycle plus mitosis divides the growth cycle into only four age-intervals 1 Changes in the tissue of interest resulting not from direct irradiation of that tissue, but indirectly from changes in organs or tissues elsewhere in the irradiated specimen.
2 Variations in cell sensitivity as a function of state of differentiation are not well known and are not treated here. s Gz M Fig. 2.9 . A survival pattern for mammalian cells as a function of age in the division cycle. The shape of this pattern is typical of what is observed after a single large given dose of low-LET radiation. Age is shown in relation to the replication and segregation cycle of nu~lear deoxyribonucleic acid (DNA): G,, presynthetic phase; S, synthetic phase; G 2 postsynthetic phase; and M, mitosis at each end of the cycle. In some cells in which G, is very short the first modal peak of this bimodal function is essentially absent (Sinclair, 1968) . In some cells a metabolicallyquiescent period, G 0 , is thought to precede G" or to be between G, andS.
(possibly five if G 0 , a non-aging or non-cycling state, is included), in general response may be expected to be a continuously-varying function of age. Denoting the dose dependence of survival at a discrete age interval i by S(D)i and the fraction of cells in age interval i by ui C:Lui = 1), for an otherwise phenotypically homogeneous population of cells the overall survival curve would be,
If a dose-effect curve changes shape through the cell cycle, the shape of the age-response pattern at a fixed dose will depend on the size of the dose. In the instance of a phenotypically heterogeneous population, a further summation would be required as discussed in Section 2.2.3.
Damage Modification
Lethal Damage. Even in the case of a single exposure, the physiological conditions during the irradiation or the metabolic events that follow may influence the degree of effect expressed by a cell. In the instance of cell survival, for example, and in the simplest case of exponential inactivation (A in Figure  2 .2) the survival curve may become less steep (or more steep) depending upon the repair (or enhancement) of potentially lethal damage during or after exposure (Hall, 1953; Elkind, 1977) . Definition: Potentially Lethal Damage: Potentially lethal dam-age is damage, the lethal expression of which may be modified by alterations in postirradiation conditions.
In a cell system, potentially lethal damage may involve the communication between cells and hence its expression could depend upon the relative config~ uration of the cells. In an organism, potentially lethal damage could involve the interaction of two or more cell systems. Potentially lethal damage might even be modifiable by preirradiation conditions leadng to postirradiation alterations, although changes m the amount of damage registered may also be involved.
Definition: Potentially Lethal Damage Repair: Repair of potentially lethal damage as indicated by a reduced response effected by alterations in postirradiation conditions. Potentially Lethal Damage Enhancement: Enhancement of potentially lethal damage as indicated by an increased response effected by alterations in postirradiation conditions.
Sublethal Damage. A non-linear dose-effect dependency of a homogeneous biological system generally reflects some form of damage accumulation process. Relative to cell killing, this can be visualized as in Figure 2 .10. Curve A in Figure 2 .lOa is a shouldertype curve which might, or might not, have a nonzero initial slope (see also B, Figure 2 .2). If the curve approaches an exponential shape with increasing dose, D q (Figure 2 .4) may be used as a measure of the capacity to accumulate sublethal damage. When a dose beyond the shoulder region, i.e., to the linear region, is received, surviving cells carry the maximum amount of sublethal damage consistent with survival (Elkind and Whitmore, 1967, Chapter 2). If the total dose to reduce survival to S (D 1 ) is D 2 , delivered in two fractions such that D 2 = 1 D 2 + 2 D 2 (see definition of >Symbols, given below), when an interval of time follows 1 D 2 , and if D 2 > D 1 then it is possible that sublethal damage has been repaired (curve B, Figure 2 .lOa). Curves C and D ( Figure  2 .lOb) illustrate the same possibility in the instance where the single-dose survival dependence is of the type that bends continuously downward (also C 
Sublethal Damage Repair: A reduction of sublethal damage due to intracellular processes. Sublethal Damage Recovery: A reduction of sublethal damage in cells, tissues or organisms due to intracellular repair and/or other processes.
Even when repopulation does not occur, or an accounting can be made of its contribution, a reduced effect after a treatment course customarily used to test for sublethal damage repair may be misleading. For example, if cells at the Gi/S border in Figure 2 .9 are exposed to a fractionated dose sequence, a lesser effect may be observed than after the same total dose delivered at one time if, in the interval, survivors of the first dose become less responsive because they progress into S. In such a situation, the reduced effect may reflect cell aging alone and neither repopulation nor repair. Similarly, when a treatment intended to test for the status of sublethal damage results in the same degree of effect or even in an enhanced effect, this does not ensure that sublethal damage repair has not occurred. For example, the enhanced response accompanying the aging of cells initially irradiated at ages at which they are resistant (e.g., early G 1 and late S, Figure 2 .9) could reduce, nullify, or even outweigh the effects of sublethal damage repair. Thus, precise interpretations of tests for the status of sublethal damage require an accounting for aging, repopulation, and transients that might influence the expression of potentially lethal damage in a given instance.
Symbols. To facilitate the description of dose fractionation effects, the following symbols are defined and illustrated in reference to cell killing in Figure   2 Di the dose to reach survival S(D1) without fractionation;
damage, which is damage that does not lead to cell death, e.g .. genetic changes, malignant transformation. D 2 the dose to reach survival S(D 1 ) with fractionation ( = 1D 2 + 2D 2 ); D 2 -D 1 the dose increment, or the "recovered dose," required as a result of fractionation, to match the effect of the single dose Di; and 1 t 2 = the fractionation interval between the first and second doses. When, after the interval 1 t 2 , graded second doses are used such that curves B and D in Figure 2 .10 are determined, then it may be possible to assign part or all of the increment (D 2 -D 1 ) to repair of sublethal damage. To do this rigorously, however, information is needed on the contributions to survival made by cell aging and/or repopulation between dose fractions as noted.
The preceding apply to 2-dose fractionation. The following symbols are to be used in the general case: N = the number of fractions; iD>s = the ith of N dose fractions; (D 1 ) after (N -1) intervals and N fractions; D 'SN = the average dose per fraction;
Dr= (D'S -D 1 )/ (N -1) the average dose increment per interval, or the "recovered dose" per interval; Ji= the length of the interval between the ith andjth doses;
'S-1 T = L it ti+ 1 , = the overall fractionation i=l period. Average Recovered Dose: The average dose increment, Dr, per interval required to reduce survival to a given value with fractionation. In general, the dose recovered will represent the combined effects of repair and repopulation and modifications of either or both of these by: cell synchrony; radiation induced delays in, cell aging; potentially lethal damage modification; and, possibly, the accumulation of unrepaired sublethal damage and other forms of heritable damage (e.g., small colony formation). Additional unidentified effects specific to target cells, or abscopal in nature, may also be involved.
Response Modification
The responses of cells, tissues, and organisms to a given dose can be altered in different ways. This is possible because responsl depends on physical factors (e.g., the quality of the radiation and the dose rate); on chemical factors (e.g., the presence or absence of electron affinic substances or hydrogen donors), and on biological or physiological factors (e.g., changes in the composition or the amount of the DNA in a cell, or changes in homeostatic control in an organism).
Reference Conditions
To express modifications in response in a quantitative way, a set of reference conditions must be specified. For the radiation, the reference is usually orthovoltage x rays ( ~ 200 kV) at a dose rate sufficiently high (for the conditions of exposure) that contributions from repair processes during irradiation are negligible, and not so high, relative to diffusion rates, that the chemical environment in the vicinity of the targets is significantly altered (e.g., by the radiochemical depletion of oxygen in solution). As in all radiobiological experiments, the biological conditions that influence the response must be specified. Except for the factor to be modified, all other factors should be the same as in the reference system. For example, if in testing for the modifying influence of hypoxia, the metabolism of a system is also changed, then whatever alteration in response results may not be due to the absence of oxygen per se.
Dose Modification
A comprehensive statement of change in a doseresponse relationship resulting from a modifier usually will require a relatively large number of observations. When dose-effect curves are available, and a simple factorial relationship does not exist between the two curves, the entire curves are required to specify the modification. In Figure 2 .11, the survival curves R and T are not functionally related in any simple way; still, a change in the dose-response relationship is apparent from the curves themselves. Definition: Dose Modification 4 Ratio: The ratio of the dose under reference conditions to that under the modified or test conditions to produce the same level of effect.
Symbol, M:
M =DR!DT (2.24)
In Equation (2.24), R stands for the reference conditions; T stands for the test conditions. Although the reference condition is specified as the numerator and is so used for some modification ratios 4 Dose modification is not to be construed to mean that the physical quantity absorbed dose is in fact modified. Rather, the magnitude of absorbed dose necessary to reach a specified level of effect is changed to the degree indicated by the dose modification ratio or factor. Note that the survival level S 1 the relative magnitudes of DR and DTare the reverse of that atS 2 • (e.g., RBE for different radiation qualities), it is recognized that the reciprocal of the defin£;d ratio is, by convention, used for other modification ratios (e.g., oxygen enhancement ratio, or OER, for different oxygen tensions; see Section 2.4.3).
As illustrated in Figure 2 .11, M may depend upon the level of effect and, therefore, this must be specified as well as any other factors that may alter the dose dependence for the reference or test conditions. To illustrate these points, in Figure 2 .11, at the two survival levels shown, the dose modification ratios would be: M(S1) = DR,i/DT,1 < 1 M(S2) = DR,2/DT,2 > 1 Equal levels of effect may result from different mechanisms. Since the biological expression ofradiation lesions usually involves a sequence of chemical and biological changes, the same end result does not necessarily specify the sequence uniquely. In view of the fact that curve shape changes may accompany use of a modifier (e.g., Figure 2 .11), a dose ratio at more than one level of effect may be required to give an adequate quantitative estimate of the pattern of modification. (Figure 2 .11 provides an uncommon but illustrative example.)
When two dose dependencies are related by a constant factor on the dose scale, dose modification ratios are independent of level of effect. In such an instance, it becomes unnecessary to specify the level of effect; the dose modification ratio is then termed a dose modification factor.
Although the dose dependence of dose modification ratios is usually determined on the basis of the doseresponse curves for the two conditions (McLarty and Thames, 1977) , it may also be derived from the discrete data that establish these curves utilizing a non-parametric approach (Kellerer and Brenot, 1973) .
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The Effect of Oxygen
An important example in radiobiology of dose modification involves the so-called "oxygen effect." This refers to the observation that oxygen enhances the radiation response observed, demonstrated for a wide variety of biological end points. Since systems usually are oxic when irradiated, and because the sensitizing effect of oxygen is close to maximal for oxygen concentration corresponding to a few percent or more in the gas phase (Elkind and Whitmore, 1967) , the usual state is one of enhanced response due to oxygenation. Although the term "oxygen effect" implies that hypoxia is the reference condition, it is common p-ractice to use air as the reference equilibration gas (100 percent 0 2 is frequently equally sensitizing); neither condition reflects necessarily the oxygen concentration in the tissue of interest. Hypoxia is usually effected by replacing air with nitrogen for gaseous equilibration. Definition: Oxygen Enhancement Ratio (OERJ: The ratio of the dose required under conditions of hypoxia to that under conditions in air to produce the same level of effect.
The dose modification due to the lack of oxygenation may be independent of the level of effect, as it frequently is when low-LET radiation is used for cell killing (Alper and Howard-Flanders, 1956; Howard-Flanders and Alper, 1957) , or mouse killing within 4 or 5 days (Homsey, 1970 (Homsey, , 1971 . The effect of hypoxia may be expressed as:
where the OER relates to the particular radiation used and M in this case is the hypoxia dose modification factor.
Relative Biological Effectiveness
Relative biological effectiveness represents the effectiveness of a given radiation, compared to a reference radiation, in producing the same level of response. Definition: Relative Biological Effectiveness (RBE): A ratio of the absorbed dose of a reference radiation to the absorbed dose of a test radiation to produce the same level of biological effect, other conditions being equal. When two radiations produce an effect that is not of the same extent and/or nature, an RBE cannot be specified.
RBE depends upon radiation quality as well as upon level and kind of effect, and hence the test conditions as well as the reference radiation must be completely specified;
(2.26) where R stands for the reference and T for the test radiation.
Gain Factor
In radiotherapy, the aim of changes in technique is to enhance the effects of the treatment on the tumor relative to normal tissue(s). The result of a change in technique (e.g., a change in radiation quality, timedose pattern, the application of hyperthermia, or the combining of chemical and radiation treatment) may be expressed by the "gain factor." Definition: Gain Factor (GF): The ratio of the dose modification factor of the tumor system, to that of the normal tissue system(s) in question.
As defined, GF strictly speaking is the ratio of two dose modification factors; i.e., two ratios each of which is derived from dose dependencies related by a constant factor on the dose scale. The notion of a gain factor is useful, however, in a number of situations in which this condition is not met. In such cases, the levels of effect at which GF is evaluated must be specified. Thus, (2.27) where the subscripts T and N refer to tumor and normal tissues, respectively. The dose modification ratios in Equation (2.27) are evaluated at given levels of effect on the tumor and normal tissues, respectively.
Some examples of the application of the concept of gain factor are the following:
(1) The gain factor for a change in radiation quality, GF quah is the ratio of RBE values, (2.28)
(2) One reason for a possible improved differential effectiveness due to a change in radiation quality concerns the reduced oxygen enhancement ratio of tumor cells a proportion of which may be hypoxic. An important example of this is the use of the gain factor in connection with a comparison between fast neutrons and a low LET radiation. For tumor cells, the following ratio applies: Thus, for OERx =3 and OERn =1.5, GF =2.
(2.30)
(3) For a change in the time-dose pattern of the exposures, the gain factor is GFume = TF N/TF T (2.31) where TF, or time factor, is equal to l/Mume· The gain factor GFume quantifies the "therapeutic gain" obtained by a change from dose-time pattern 1 to dose-time pattern 2, which is also given by, (2.32)
Damage lnteraction 5
When two or more radiations are used to produce a given effect, the combined dose-effect dependence may yield information relative to intracellular damage interaction. This can be illustrated by means of Figure 2 .12 where several survival curves are shown; similar considerations apply to other lethal agents and end points. If radiation X reduces survival according to A, a dose Yi of radiation Y that reduces survival to S (yi) is equivalent to dose Xi of radiation X. Irradiating with graded doses ofX, each combined with dose Yb in principle, may give a variety of results as follows. IfB results such that Bis the same as A replotted with the origin shifted from coordinates [0, 1) to [xii S(yi)], it may be concluded that the damage produced by Yi is independent of that due to X; that is, S(yi + x) = S(xi + x) (2.34) wherex in Equation (2.33) is the dose from the second origin. Definition: Independent Action: A dose-effect dependence for radiation X, not infiuenced by an exposure to radiation Y. If A' results where A' is superimposed on A, it may be concluded that the damage due to Yi is additive to that produced by X; that is, Definition: Additive Action: A dose-effect dependence in which Examples of combined survival effects due to radiation (or treatment) Y and radiation (or treatment) X. Curve A is the single-dose survival curve due to X. After a dose yi, equivalent in effect to xi, the survival curve of graded doses of X could be: A, additive action; B, independent action (A' has the same shape as A); C synergistic action, and D, antagonistic action. the additional effect produced by radiation X adds to that due to radiation Y as though the effect due to Y was produced by a biologically equivalent dose of X. If C results, it may be concluded that the damage due toy; is synergistic with that due to X; that is, S(y; + x) < S(x; + x) (2.35) Definition: Synergistic Action: A dose-effect dependence in which the additional effect produced by radiation X, in combination with a fixed dose of radiation Y, is more effective than X alone when account is taken of a dose of X biologically equivalent to Y. And finally, if D results, it may be concluded that 2.5 Damage Interaction • • • 15 the damage due toy; is antagonistic to that due to X; that is, S(y; + x) > S(x; + x) (2.36) Definition: Antagonistic Action: A dose effect dependence in which the additional effect produced by radiation X, in combination with a fixed dose of radiation Y, is less effective than X alone when account is taken of a dose of X biologically equivalent to Y. In the above definitions, the radiations in question are assumed to be delivered rapidly enough that possible biological modifications of the products of energy deposition by one radiation do not occur before the other is delivered. Also, in order to apply these definitions to intracellular effects, questions of population selection must be taken into account. For example, cell killing due to radiations Y and X may be greater than that due to independent action if the survivors of Y happen to be particularly sensitive to X. In such an instance, independent action may still be involved, the apparent enhanced killing being the result of cells resistant to Y being inherently sensitive to X.
The preceding discussion, sketched in Figure 2 .12 and specified by Equations \2.28) through (2.36), illustrates the three survival domains that may result from the combined use of two radiations. It should be noted, however, that the net effectiveness of two radiations may be dose dependent and hence, the shapes of the curves in Figure 2 .12, and the equality or inequality signs in Equations (2.28) through (2.36), may depend on the dose ranges involved.
